Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Brain Research|April 21, 1987
Diabetes-induced changes in monoamine concentrations of rat hypothalamic nucleiM S Bitar, M Koulu, M Linnoila
Life Sciences|January 1, 1992
Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker ratsJ Rouru, R Huupponen, U Pesonen, et al.
Acta Veterinaria Scandinavica. Supplementum|January 1, 1989
Pharmacological effects of medetomidine in humansH Scheinin, A Kallio, M Koulu, et al.
Brain Research. Molecular Brain Research|June 1, 1991
Effects of repeated administration of mifepristone and 8-OH-DPAT on expression of preproneuropeptide Y mRNA in the arcuate nucleus of obese Zucker ratsU Pesonen, J Rouru, R Huupponen, et al.
Acta Pharmacologica Et Toxicologica|August 1, 1984
Determination of conjugated dopamine in cerebrospinal fluid from humans and non-human primates with high performance liquid chromatography using electrochemical detectionM Scheinin, T Seppala, M Koulu, et al.
The Journal of Endocrinology|March 1, 1992
The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker ratsU Pesonen, M Koulu, O Heikinheimo, et al.
Psychopharmacology|January 1, 1990
Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor bindingM Koulu, J Lappalainen, J Hietala, et al.
Research Communications in Chemical Pathology and Pharmacology|February 1, 1993
Metformin and liver glycogen synthase activity in obese Zucker ratsR Huupponen, K Pyykkö, M Koulu, et al.
Methods and Findings in Experimental and Clinical Pharmacology|August 1, 1985
Neuroendocrine aspects in monitoring of dopaminergic drugs in manJ Hietala, M Koulu, M Scheinin, et al.
Brain Research|March 6, 1992
Alpha 2-adrenoceptor density in forebrain areas of Zucker rats: no effect of genetic obesity or antiglucocorticoid treatmentU Pesonen, T Miettinen, M Scheinin, et al.
Pageof 11